Epilepsy is the most prevalent chronic neurological disorder and is a major public health concern, directly affecting an estimated 50 million people worldwide and involving an additional 500 million people as family members and caregivers of patients. [1] Despite the recent introduction of a range of new anti-epileptic drugs (AEDs) over the last 10 years, the problem of drug-resistant or drug-refractory epilepsy has not changed signifi cantly, and 30% of the patients continue to be resistant to multiple AEDs. [2] Mesial temporal lobe epilepsy (MTLE)
is the most common medically refractory epilepsy syndrome in adults, and hippocampal sclerosis (HS)
is the most frequently encountered lesion in patients with MTLE. [3] The abundant premature accumulation of corpora amylacea (CoA) in the hippocampus has emerged as a distinctive marker of HS, which is seen in 50-60% of the subjects. [4, 5] These are spherical, basophilic structures, which normally accumulate in the perivascular and subpial regions of the central nervous system as a result of aging and other neurodegenerative 
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conditions like Alzheimer's disease and Parkinson's disease. [6] The extent of accumulation of CoA has been correlated with seizure duration and interictal psychosis in patients with MTLE-HS. [5] In this regard, the detection of CoA, a pathological marker of neurodegeneration, in the surgical specimens of patients with MTLE-HS is of special interest and deserves a closer scrutiny to elucidate the possible pathomechanisms of HS.
Interestingly, the promotion of CoA formation has been linked to cellular stress, in particular oxidative stress and mitochondrial dysfunction. [6] As recurrent seizures induce signifi cant oxidative stress in the hippocampus, it is likely that CoA formation ensues as a buffer response to seizure-induced excitotoxic damage in the hippocampal neuronal and glial cells. [5] P-glycoprotein (P-gp), an ATPdependent effl ux pump with a broad substrate specifi city, encoded by the ABCB1 gene, is postulated to mediate at least part of the drug resistance. [2, 7] The expression of ABCB1 in the epileptic foci of drug-resistant epilepsy was found to be several-fold elevated in both animal and human studies, indicating its signifi cant role in epilepsy.
The C3435T, a major allelic variant of the ABCB1 gene, is proposed to play a crucial role in drug resistance in epilepsy. The C/C genotype carriers reportedly are at a higher risk of pharmacoresistance to AEDs, and this issue has been extensively investigated with confl icting results. [2] The recent meta-analyses have failed to confi rm an association between the ABCB1 C3435T polymorphism and the risk of drug resistance, suggesting a revision in contribution of this polymorphism in the multi-drug transporters hypothesis of drug resistance in epilepsy. [8] [9] [10] In addition to the effl ux transporter function, P-gp plays an important role in tissue defence through the excretion of toxic compounds and their metabolites, especially in the presence of oxidative stress. [11, 12] Hence, the overexpression of ABCB1 gene products might be a tissue response to the oxidative stress of epilepsy.
Uwai et al. reported an intron 16 polymorphism (Ex-76
T/A) that resulted in downregulation of P-gp function in renal carcinoma cells. [13] The Ex-76 T/A has been shown to be in linkage disequilibrium with G2677T
and the alleles of Ex-76 T/A formed major haplotypes with G2677T and C3435T. [14] We hypothesized that a similar polymorphism will be found in patients with
CoA deposition as the polymorphism predisposes the 
Materials and Methods

Selection of subjects
The epilepsy patients were recruited through the were seizure-free for more than 1 year after surgery.
We recruited 46 consecutive patients with MTLE who had undergone anterior temporal lobectomy and had pathologically verifi ed HS. The details of our noninvasive presurgical evaluation protocol have been described previously. [16] We excluded subjects with HS associated with temporal lobe neoplasms (secondary HS).
Surgical procedure
For MTLE-HS, we performed an en bloc standard anterior temporal lobectomy with amygdalohippocampectomy. [16] After a standard temporal craniotomy, under general anesthesia, which exposed approximately 8 cm of the temporal lobe and the inferior frontal gyrus, a 5-6-cm block of temporal lateral cortex along with superior temporal gyrus was resected depending on temporal lobe dominance and the presence of prominent cortical vessels. The anterior two-thirds of the hippocampus and the lateral two-thirds of the amygdala were resected en bloc along with the uncus and parahippocampal gyrus by subpial dissection using the operating microscope.
Pathological examination
Four-micrometer-thick histological sections of the resected temporal lobe were generated from 10%
formalin-fi xed, paraffi n-embedded tissue. In addition to the routine hematoxylin and eosin stain, we stained the hippocampal sections with Luxol fast blue-Periodic G2677T/A (rs2032582) and Ex26 C3435T (rs1045642)
[ Table 1 ]. The genotyping was carried out at the
Department of Human Molecular Genetics, Rajiv Gandhi
Center for Biotechnology, Trivandrum, India. Blood samples were obtained after informed consent and the study was approved by the Institutional Ethics Committee for biomedical subjects as per the Indian Council of Medical Research (ICMR) guidelines. [17] Blood samples (5 ml) were drawn into EDTA vials and genomic DNA was isolated from human leukocytes by standard methods.
Polymerase chain reaction (PCR) was carried out in a total volume of 10 μl containing 50 ng DNA, 250 μM dNTP (Amersham Pharmacia Biotech, Uppsala, Sweden), 10 pmol of each primer (Table) , 1X PCR buffer (Bangalore Genei, Bangalore, India) and 0.5 U Taq polymerase enzyme (Bangalore Genei). PCR was programmed for initial denaturation at 95°C for 5 min, followed by 35 
Statistical methods
We summarized the quantitative data as mean ± EHPLUS and the log-linear modelling of Mander. [18] Binary logistic regression was used to adjust for age, sex and seizure duration. Association was expressed as odds ratios (OR) or risk estimates with 95% confi dence intervals (CI). Association was considered signifi cant at P <0.05. All analyses were performed using SPSS statistical analysis software, Version 17.0 (SPSS, Chicago, IL, USA).
Results
Patient characteristics
Of the 46 (26 male and 20 female) MTLE-HS patients who were included in the study, 24 (52.1%) were MTLE- The distribution of variables among the MTLE-HS-CoA+ and the MTLE-HS-CoA− groups of patients is compared in Table 2 , and is elaborated.
Clinical features
The age at surgery was found to be signifi cantly 
Genotypic analysis
Patients in the MTLE-HS-CoA+ group were more likely to have the TA genotype at ABCB1 Ex -76T/A compared with those in the MTLE-HS-CoA− group (70% versus 31.8%, P = 0.016, OR = 5, 95% CI = 1.34-18.5) [ Table 3 ].
Signifi cant differences were observed at the allele level also (P = 0.04). After adjustment of the odds ratios for age at surgery, sex, age at onset, duration of epilepsy and 
Discussion
In this study, using a strict phenotypic defi nition, we found an association between the intronic polymorphic Interestingly, in a situation of organ damage or disease, changes in the expression levels of ABC transporters have been observed, probably to compensate for the increased load of harmful products of oxidative stress formed during an insult or to compensate for the loss of effl ux pumps in damaged tissue. [12] In addition to its protective function, P-gp has also been implicated in resistance to apoptosis, most importantly by inhibiting Fas-induced caspase-3 activation and by modulating ceramide metabolism. [12, 20] Hence, the overexpression of ABCB1 gene products at the site of tissue damage is a physiological phenomenon for tissue defense. Overexpression of ABCB1 in the epileptic tissue, both in animal and human tissue, was one of the key evidence to propose its role in drug resistance in epilepsy. [21, 22] The expression of ABCB1 in the epileptic foci of drug-resistant epilepsy patients was shown to be elevated 10-fold. [23] Elevated levels of ABCB1 and multidrug-associated protein (ABCC1/MRP1) have also been associated with pathologies associated with drug refractoriness, such as in tuberous sclerosis and also in epileptic tissue surrounding dysembryoplastic neuroepithelial tumors, focal cortical dysplasia and hippocampal sclerosis. The adjacent nonepileptic tissue from the same patients did not show elevated expression of the transporter. [24] In 2003, Siddiqui et al. [25] reported the C3435T polymorphism in the ABCB1 gene as being associated with resistance to multiple AEDs, and leading to the suggestion, for the fi rst time, that drug resistance in epilepsy might be genetically determined. Since then, several other genetic association studies have attempted to verify this result; however, taken overall, the role of P-gp in drug resistance in epilepsy still remains uncertain. [2] Three recent meta-analyses addressed the issue. [8] [9] [10] The fi rst report in 1073 Caucasians patients included three studies with the same defi nition of drug responsiveness and drug resistance, [8] and the second one included 11 studies involving 3371 patients with different ethnicities, but the same defi nition of drug responsiveness and drug resistance. [9] Neither of these studies could confi rm this association and stratifi cation of ethnic subgroups in the second meta-analysis also provided no further evidence. [15] and ethnicity, to address the issue of different defi nitions of drug responsiveness and drug resistance in the patients with various ethnicities, did not show any association under all genetic models. [10] Hence, in view of these data, we may have to revise the role for ABCB1 gene in epilepsy and more importance must be attributed to its role in tissue defense in epileptic tissue. The role of CoA in sequestration of toxic cellular metabolites is being increasingly recognized and is supported by the presence of ubiquitin and heat shock proteins in CoA and its abundant accumulation in neurodegenerative diseases, where oxidative stress and mitochondrial dysfunction are common denominators compared with age-matched controls. [6] In patients with MTLE-HS, premature accumulation of CoA in the hippocampus might be a refl ection of a tissue reaction to buffer the free radicals and other toxic metabolites generated as a result of repeated seizures. Our observation in this and previous studies [5] of the association between older age and longer duration of epilepsy with CoA accumulation in the hippocampus is in agreement with this hypothesis.
Is there a relationship between ABCB1 polymorphisms and CoA accumulation that we observed in our wellcharacterized MTLE-HS patients? We hypothesize a link through the tissue defense function of ABCB1-encoded P-gp. The Ex-76 T/A has been shown to be in linkage disequilibrium with G2677T and the alleles of Ex-76 T/A formed major haplotypes with G2677T and C3435T. [14] Although data to date are mainly available for coding SNPs in exons 21 and 26, Uwai et al. [13] found that Ex-76 T/A (intron 16) polymorphism resulted in downregulation of P-gp function in renal carcinoma cells. We hypothesize that downregulation of P-gp function predisposes the hippocampal neuronal and glial cells to seizure-induced excitotoxic damage and CoA formation ensues as a buffer response. Our results demonstrate that ABCB1 polymorphisms are associated with CoA deposition in MTLE-HS patients in south Indian patients, and further substantiate the need to revise its role in epilepsy genetics. However, the association found in our study is modest, most likely due to the small sample size. As the stringent selection criteria resulted in the small sample size, haplotype analysis was not possible. As the G2677T polymorphism (genotypic and allelic) was also found to be associated with CoA deposition and the Ex-76 T/A has been shown to be in linkage disequilibrium with G2677T, the haplotypic analysis would be interesting. Hence, a further study with a larger sample size and P-glycoprotein functional expression studies will be required to establish the relationship between Ex-76 T/A polymorphism and CoA accumulation.
